PD
Dhiwar PS
Alard School of Pharmacy, Mahalaxmi Institute of Pharmacy, Acharya and BM Reddy College of Pharmacy, National Institute of Pharmaceutical Education and Research
Employment
-
Alard School of Pharmacy Assistant Professor2026 - Present
-
Mahalaxmi Institute of Pharmacy Principal2025 - 2025
-
Acharya and BM Reddy College of Pharmacy JRF & PhD Scholar2018 - 2024
Education
-
Acharya and BM Reddy College of Pharmacy Ex-JRF and PhD Scholar2019 - 2024
-
National Institute of Pharmaceutical Education and Research M.S. (Pharm)2016 - 2018
-
Smt Kashibai Navale College of Pharmacy B.Pharm2012 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Anti-cancer potential of Cyperus tegetum: GC-MS & LC-MS Profiling, in-vitro and in silico studies targeting DHODH and DDX3X Save
- Therapeutic Potential of Isoflavonoids in Cancer Therapy: Comprehensive Insight into Biological Activities, Molecular Targets, and Structure–Activity Relationships Save
- Medicinal chemistry perspective of chalcone derivatives as anticancer agents: synthetic strategy, biological activity, and structure-activity relationship Save
- Pyrimidine-based HER2 inhibitors: Design, synthesis, biological evaluation, and molecular modeling for breast cancer therapy Save
- Unveiling antidiabetic mechanisms of Raphanus sativus L. leaves: a multidimensional approach combining in vitro, in vivo, and in silico studies Save
- Exploration of Antidiabetic and Anti-Apoptotic Activity of Cissus quadrangularis Stem Through Mechanistic Pathway: An in vitro, in silico and in vivo Approach Save
- Comprehensive Analysis of Antidiabetic Properties in Raphanus sativus Leaves: A Synergistic In-Silico and In-Vitro Approach Save
- In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies Save
- An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review Save
- Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors Save